The role of the ceRNA network mediated by lncRNA SNHG3 in the progression of cancer
- PMID: 39349640
- PMCID: PMC11442963
- DOI: 10.1007/s12672-024-01184-w
The role of the ceRNA network mediated by lncRNA SNHG3 in the progression of cancer
Abstract
Background: Long non-coding RNAs (lncRNAs) are a distinct class of RNAs with longer than 200 base pairs that are not translated into proteins. Small Nucleolar RNA Host Gene 3 (SNHG3) is a lncRNA and frequently dysregulated in various human cancers.
Objective: This review provides a comprehensive analysis of current research on lncRNA SNHG3, focusing on its role within the competitive endogenous RNA (ceRNA) network and its implications in cancer.
Methods: A systematic literature review was conducted using PubMed up to October 2023. The search strategy included keywords such as "lncRNA SNHG3", "competitive endogenous RNA", "cancer", and related terms. Studies were selected based on relevance to SNHG3's involvement in cancer pathogenesis and progression.
Results: Disruptions in the ceRNA network involving lncRNA SNHG3 can impair normal cell growth and differentiation, significantly contributing to disease pathogenesis, particularly cancer. This review highlights SNHG3's substantial impact on various cancer processes and its potential as a diagnostic and therapeutic tool for aggressive cancers.
Conclusion: The findings underscore SNHG3's pivotal role in cancer prevention, diagnosis, and treatment, laying a foundation for future research in cancer management. Insights from this review emphasize the necessity for further exploration and development of SNHG3-based diagnostic and therapeutic strategies.
Keywords: Competitive endogenous RNAs; Human cancer; LncRNA SNHG3,; Long non-coding RNA; Potential therapeutic target,; Tumorigenesis biomarker,.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
LncRNA SNHG3, a potential oncogene in human cancers.Cancer Cell Int. 2020 Nov 4;20(1):536. doi: 10.1186/s12935-020-01608-x. Cancer Cell Int. 2020. PMID: 33292213 Free PMC article. Review.
-
LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.J Cell Mol Med. 2020 Aug;24(16):9231-9243. doi: 10.1111/jcmm.15564. Epub 2020 Jun 28. J Cell Mol Med. 2020. PMID: 32596993 Free PMC article.
-
Small nucleolar RNA host gene 3 functions as a novel biomarker in liver cancer and other tumour progression.World J Gastroenterol. 2022 Apr 28;28(16):1641-1655. doi: 10.3748/wjg.v28.i16.1641. World J Gastroenterol. 2022. PMID: 35581965 Free PMC article. Review.
-
LncRNA SNHG3 Promotes Proliferation and Metastasis of Non-Small-Cell Lung Cancer Cells Through miR-515-5p/SUMO2 Axis.Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211019376. doi: 10.1177/15330338211019376. Technol Cancer Res Treat. 2021. PMID: 34032148 Free PMC article.
-
[Screening of the lncRNA SNHG3 regulating CART expression in the bovine hypothalamus].Sheng Wu Gong Cheng Xue Bao. 2024 Jul 25;40(7):2162-2177. doi: 10.13345/j.cjb.230656. Sheng Wu Gong Cheng Xue Bao. 2024. PMID: 39044582 Chinese.
Cited by
-
Role of ncRNAs in the Development of Chronic Pain.Noncoding RNA. 2025 Jul 3;11(4):51. doi: 10.3390/ncrna11040051. Noncoding RNA. 2025. PMID: 40700093 Free PMC article. Review.
References
-
- Mertens D, Stilgenbauer S. Prognostic and predictive factors in patients with chronic lymphocytic leukemia: relevant in the era of novel treatment approaches? J Clin Oncol. 2014;32(9):869–72. 10.1200/jco.2013.53.8421. - PubMed
-
- Wagner S, Sharma SJ, Wuerdemann N, Knuth J, Reder H, Wittekindt C, et al. Human papillomavirus-related head and neck cancer. Oncol Res Treat. 2017;40(6):334–40. 10.1159/000477252. - PubMed
-
- Magri V, Boltri M, Cai T, Colombo R, Cuzzocrea S, De Visschere P, et al. Multidisciplinary approach to prostatitis. Arch Ital Urol Androl. 2019;90(4):227–48. 10.4081/aiua.2018.4.227. - PubMed
Publication types
Grants and funding
- Guiweikejiaofa [2020]-15/Guangxi Training Program for Medical High-level Academic Leaders
- 2020-3-2/Bose Talent Highland
- 2024/Building Projects of Guangxi Bagui Scholars
- Guiweikejiaofa [2020]-17/Building Projects from the Key Laboratory of Molecular Pathology (Hepatobiliary Diseases) of Guangxi
- Guijiaokeyan [2022]-10/the Key Laboratory of Tumor Molecular Pathology of Guangxi Colleges & Universities
LinkOut - more resources
Full Text Sources